1-3 of 3
Karin Garming-Legert
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Thymic Function Predicts Response to Mesenchymal Stromal Cell Treatment in Chronic GvHD: A Phase II Clinical Study

Erik Boberg, Lena Von Bahr, MD PhD, Nina Heldring, PhD, Gabriel Afram, MD, Ellen Iacobaeus, MD PhD, Carina Lindström, RN, Karin Garming-Legert, DMD, PhD, Per Ljungman, Rachael Sugars, PhD, Lindsay Davies, MD PhD, Nadir Kadri, PhD, Katarina Le Blanc, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3253.
https://doi.org/10.1182/blood.V130.Suppl_1.3253.3253
Published: 2017
Journal Articles

Treatment of Chronic GvHD with Mesenchymal Stromal Cells Induces Durable Responses; A Phase II Study

Lena Von Bahr, MD, Lindsay Davies, PhD, Gabriel Afram, MD, Carina Modin, Karin Garming-Legert, PhD, Hans Hägglund, MD PhD, Per T. Ljungman, MD PhD, Katarina Le Blanc, MD, PhD
Journal: Blood
Blood (2015) 126 (23): 3138.
https://doi.org/10.1182/blood.V126.23.3138.3138
Published: 2015
Journal Articles

Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease

J. Marius Munneke, Andreas T. Björklund, Jenny M. Mjösberg, Karin Garming-Legert, Jochem H. Bernink, Bianca Blom, Cynthia Huisman, Marinus H. J. van Oers, Hergen Spits, Karl-Johan Malmberg, Mette D. Hazenberg
Journal: Blood
Blood (2014) 124 (5): 812–821.
https://doi.org/10.1182/blood-2013-11-536888
Published: 2014
Includes: Supplemental data